Enantioselective Decarboxylative Alkylation Reactions: Catalyst Development, Substrate Scope, and Mechanistic Studies
- Creators
- Behenna, Douglas C.
-
Mohr, Justin T.
- Sherden, Nathaniel H.
-
Marinescu, Smaranda C.
- Harned, Andrew M.
- Tani, Kousuke
- Seto, Masaki
- Ma, Sandy
- Novák, Zoltán
-
Krout, Michael R.
- McFadden, Ryan M.
-
Roizen, Jennifer L.
- Enquist, John A., Jr.
- White, David E.
- Levine, Samantha R.
- Petrova, Krastina V.
- Iwashita, Akihiko
-
Virgil, Scott C.
-
Stoltz, Brian M.
Abstract
α-Quaternary ketones are accessed through novel enantioselective alkylations of allyl and propargyl electrophiles by unstabilized prochiral enolate nucleophiles in the presence of palladium complexes with various phosphinooxazoline (PHOX) ligands. Excellent yields and high enantiomeric excesses are obtained from three classes of enolate precursor: enol carbonates, enol silanes, and racemic β-ketoesters. Each of these substrate classes functions with nearly identical efficiency in terms of yield and enantioselectivity. Catalyst discovery and development, the optimization of reaction conditions, the exploration of reaction scope, and applications in target-directed synthesis are reported. Experimental observations suggest that these alkylation reactions occur through an unusual inner-sphere mechanism involving binding of the prochiral enolate nucleophile directly to the palladium center.
Additional Information
© 2011 Wiley-VCH Verlag GmbH&Co. KGaA, Weinheim. Received: November 24, 2010; Revised: July 29, 2011; Published online: November 14, 2011. This publication is based on work supported by award number KUS-11–006–02, made by the King Abdullah University of Science and Technology (KAUST). We thank the NIH-NIGMS (R01 GM080269–01 and postdoctoral fellowships to AMH and DEW), The Fannie and John Hertz Foundation (predoctoral fellowship to DCB), Eli Lilly (predoctoral fellowships to JTM, RMM, and MRK), Ono Pharmaceutical Co., Ltd. (postdoctoral fellowship to KT), The Hungarian–American Enterprise Scholarship Fund (postdoctoral fellowship to ZN), Takeda Pharmaceutical Co., Ltd. (postdoctoral fellowship to MS), The California Tobacco-Related Disease Research Program of the University of California (predoctoral fellowship to JLR, grant number 14DT-0004), Marcella R. Bonsall and the Dalton Fund (undergraduate fellowships to SRL), the Caltech Amgen Scholars Program (undergraduate fellowship to KVP), The 21st Century COE Program for Frontiers in Fundamental Chemistry from the Ministry of Education, Culture, Sports, Science and Technology, Japan (financial support to AI), the A. P. Sloan Foundation, Research Corporation, the Dreyfus Foundation, Bristol–Myers Squibb, Glaxo-SmithKline, Johnson and Johnson, Amgen, Merck Research Laboratories, Pfizer, Novartis, Roche, Abbott Laboratories, Boehringer–Ingelheim, AstraZeneca, and Caltech for financial support. We acknowledge Dr. Mike Day and Larry Henling for assistance with X-ray crystallography. Ruthenium olefin metathesis catalysts were generously donated by Materia.Attached Files
Accepted Version - chem_201003383_sm_miscellaneous_information.pdf
Accepted Version - nihms377540.pdf
Files
Name | Size | Download all |
---|---|---|
md5:70f7225d4c23b49d785bf34dcbeb6de6
|
27.2 MB | Preview Download |
md5:4eb56a9b8695610d23b5879708bc226a
|
10.0 MB | Preview Download |
Additional details
- PMCID
- PMC3365686
- Eprint ID
- 29280
- DOI
- 10.1002/chem.201003383
- Resolver ID
- CaltechAUTHORS:20120214-111558996
- King Abdullah University of Science and Technology (KAUST)
- KUS-11– 006–02
- NIH
- R01 GM080269–01
- NIH Postdoctoral Fellowships
- Fannie and John Hertz Foundation
- Eli Lilly
- Ono Pharmaceutical Co., Ltd
- Hungarian–American Enterprise Scholarship Fund
- Takeda Pharmaceutical Co., Ltd.
- California Tobacco-Related Disease Research Program
- 14DT-0004
- Marcella R. Bonsall
- Dalton Fund
- Caltech Amgen Scholars Program
- Alfred P. Sloan Foundation
- Research Corporation
- Camille and Henry Dreyfus Foundation
- Bristol–Myers Squibb
- Glaxo-SmithKline
- Johnson and Johnson
- Amgen
- Merck Research Laboratories
- Pfizer
- Novartis
- Roche
- Abbott Laboratories
- Boehringer–Ingelheim
- AstraZeneca
- Caltech
- Ministry of Education, Culture, Sports, Science and Technology (MEXT)
- Created
-
2012-02-14Created from EPrint's datestamp field
- Updated
-
2021-11-09Created from EPrint's last_modified field